The Intersection of DNA Damage Response and Ferroptosis-A Rationale for Combination Therapeutics

被引:27
作者
Chen, Po-Han [1 ,2 ,3 ]
Tseng, Watson Hua-Sheng [1 ,2 ,4 ]
Chi, Jen-Tsan [1 ,2 ]
机构
[1] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC 27710 USA
[2] Duke Univ, Sch Med, Ctr Genom & Computat Biol, Durham, NC 27710 USA
[3] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA
[4] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan
来源
BIOLOGY-BASEL | 2020年 / 9卷 / 08期
关键词
ferroptosis; DNA damage; ATM; ATR; p53; MDM2; MDMX; CELL-DEATH; ATM ACTIVATION; P53; ACTIVATION; ATAXIA-TELANGIECTASIA; ONCOPROTEIN MDM2; HIPPO PATHWAY; PROTEIN; PHOSPHORYLATION; PROMOTES; METABOLISM;
D O I
10.3390/biology9080187
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Ferroptosis is a novel form of iron-dependent cell death characterized by lipid peroxidation. While the importance and disease relevance of ferroptosis are gaining recognition, much remains unknown about its interaction with other biological processes and pathways. Recently, several studies have identified intricate and complicated interplay between ferroptosis, ionizing radiation (IR), ATM (ataxia-telangiectasia mutated)/ATR (ATM and Rad3-related), and tumor suppressor p53, which signifies the participation of the DNA damage response (DDR) in iron-related cell death. DDR is an evolutionarily conserved response triggered by various DNA insults to attenuate proliferation, enable DNA repairs, and dispose of cells with damaged DNA to maintain genome integrity. Deficiency in proper DDR in many genetic disorders or tumors also highlights the importance of this pathway. In this review, we will focus on the biological crosstalk between DDR and ferroptosis, which is mediated mostly via noncanonical mechanisms. For clinical applications, we also discuss the potential of combining ionizing radiation and ferroptosis-inducers for synergistic effects. At last, various ATM/ATR inhibitors under clinical development may protect ferroptosis and treat many ferroptosis-related diseases to prevent cell death, delay disease progression, and improve clinical outcomes.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 50 条
  • [21] Phosphorylation of histone H2AX at M phase in human cells without DNA damage response
    Ichijima, Y
    Sakasai, R
    Okita, N
    Asahina, K
    Mizutani, S
    Teraoka, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 336 (03) : 807 - 812
  • [22] Priming and potentiation of DNA damage response by fibronectin in human colon cancer cells and tumor-derived myofibroblasts
    de Wever, Olivier
    Sobczak-Thepot, Joelle
    Vercoutter-Edouart, Anne-Sophie
    Michalski, Jean-Claude
    Ouelaa-Benslama, Radia
    Stupack, Dwayne G.
    Bracke, Marc
    Wang, Jean Y. J.
    Gespach, Christian
    Emami, Shahin
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 39 (02) : 393 - 400
  • [23] DNA damage responses in murine Pre-B cells with genetic deficiencies in damage response genes
    Innes, Cynthia L.
    Hesse, Jill E.
    Morales, Abigail J.
    Helmink, Beth A.
    Schurman, Shepherd H.
    Sleckman, Barry P.
    Paules, Richard S.
    CELL CYCLE, 2020, 19 (01) : 67 - 83
  • [24] Reclassifying Hepatic Cell Death during Liver Damage: Ferroptosis-A Novel Form of Non-Apoptotic Cell Death?
    Macias-Rodriguez, Ricardo U.
    Inzaugarat, Maria Eugenia
    Ruiz-Margain, Astrid
    Nelson, Leonard J.
    Trautwein, Christian
    Javier Cubero, Francisco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (05)
  • [25] DNA Damage Response and Autophagy: A Meaningful Partnership
    Eliopoulos, Aristides G.
    Havaki, Sophia
    Gorgoulis, Vassilis G.
    FRONTIERS IN GENETICS, 2016, 7
  • [26] Structural basis of the (in)activity of the apical DNA damage response kinases ATM, ATR and DNA-PKcs
    Jansma, Marijke
    Hopfner, Karl-Peter
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2021, 163 : 120 - 129
  • [27] Activation of DNA Damage Response by Antitumor Therapy Counteracts the Activity of Vinca Alkaloids
    Ehrhardt, Harald
    Pfeiffer, Sarah
    Schrembs, David
    Wachter, Franziska
    Grunert, Michaela
    Jeremias, Irmela
    ANTICANCER RESEARCH, 2013, 33 (12) : 5273 - 5287
  • [28] MKK7 and ARF New players in the DNA damage response scenery
    Kotsinas, Athanassios
    Papanagnou, Panagiota
    Galanos, Panagiotis
    Schramek, Daniel
    Townsend, Paul
    Penninger, Josef M.
    Bartek, Jiri
    Gorgoulis, Vassilis G.
    CELL CYCLE, 2014, 13 (08) : 1227 - 1236
  • [29] A UVB-hypersensitive mutant in Arabidopsis thaliana is defective in the DNA damage response
    Sakamoto, Ayako N.
    Lan, Vo Thi Thuong
    Puripunyavanich, Vichai
    Hase, Yoshihiro
    Yokota, Yuichiro
    Shikazono, Naoya
    Nakagawa, Mayu
    Narumi, Issay
    Tanaka, Atsushi
    PLANT JOURNAL, 2009, 60 (03) : 509 - 517
  • [30] Radiopotentiation Profiling of Multiple Inhibitors of the DNA Damage Response for Early Clinical Development
    Gill, Sonja J.
    Wijnhoven, Paul W. G.
    Fok, Jacqueline H. L.
    Lloyd, Rebecca L.
    Cairns, Jonathan
    Armenia, Joshua
    Nikkila, Jenni
    Lau, Alan
    Bakkenist, Christopher J.
    Galbraith, Susan M.
    Vens, Conchita
    O'Connor, Mark J.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (09) : 1614 - 1626